Liver disease (hepatitis, cirrhosis) decisions — 2011

The Board has remanded the case for additional development, including obtaining SSA records and scheduling VA examinations to determine if the Veteran's hepatitis C is related to service. The claims will be readjudicated after these actions are completed.

The Board has determined that hepatitis C is at least as likely as not related to the Veteran's period of active service, and thus grants service connection for hepatitis C.

The Veteran's hepatitis C is determined to be the result of an injury in active service, and service connection for this condition is granted.

The Board has remanded the case for additional development, including obtaining private medical records and attempting to locate unit morning reports. The Veteran's claim of service connection for hepatitis C is pending.

The Board has reopened the claim of service connection for residuals of hepatitis but finds that there is no current disability. The Veteran's vision disorder was not shown to be related to his military service.

The Veteran's service-connected disabilities do not render him totally unemployable, as he is capable of securing and following a substantially gainful occupation.

The Veteran's death was not caused by a service-connected disability. The Board denied the claim for service connection for cause of death and did not find any circumstances under which DIC benefits could be granted under 38 U.S.C.A. § 1318.

The Veteran's appeal is being remanded due to the need for a Travel Board hearing. The issues of service connection are not addressed as this is a procedural matter.

The Veteran's hepatitis C is not considered to be related to his August 2006 VA surgery, and the Board finds that it was more likely due to his history of intravenous drug use. As a result, the claim for compensation under 38 U.S.C.A. § 1151 has been denied.

The Board has remanded the case for further development due to inadequate opinions regarding the etiology of the Veteran's hepatitis C and migraine headaches, as well as whether these conditions are related to service-connected PTSD.

The Board has granted service connection for hepatitis C and secondary service connection for cirrhosis of the liver, finding that both conditions are related to military service.

The Board found that the Veteran's hepatitis C infection is not etiologically related to his active service and denied the claim.

The Board has remanded the case for further development, including an opinion regarding the cause of death and whether service connection can be granted based on exposure to herbicides. The nonservice-connected pension issue is also pending.

The Board has remanded the case due to new evidence submitted by the appellant and incomplete service treatment records. The claims for service connection for double vision and an initial compensable rating for hepatitis C will be reconsidered.

The Board has remanded the case for additional development, including obtaining medical records and a VA opinion on the nature and etiology of the Veteran's hepatitis C.

The Board has determined that a VA examination is needed to determine the nature and etiology of any hepatitis C present, as well as whether it is related to service. The case will be returned for further development.

The Board found that the Veteran's hepatitis C was more likely due to his history of IV drug use during military service, and not related to air gun vaccinations or any other exposure. As a result, the claim for service connection was denied.

The Board found that hepatitis C was not incurred in or aggravated by service, and denied the Veteran's claim for service connection.

The Board finds that the Veteran's claims for service connection for various conditions, including right knee disability, left knee disability, right hip disability, hemorrhoids, hepatitis C, and hypertension, cannot be granted as there is no evidence linking these conditions to his military service.

The Board found that there is no evidence to support a service connection for hepatitis C or liver cancer, and denied both claims.